A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...

GREENVILLE, S.C.--(BUSINESS WIRE)--Crossroads Treatment Centers (Crossroads), a leading provider of substance use disorder treatment, recently introduced injectable medications as a new treatment ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the ...

Turning to medications to help you reach your weight loss goals was once taboo, but with new advancements and telehealth ...

Popular weight-loss and type 2 diabetes drugs such as Wegovy and Ozempic are typically taken as self-administered injections—a bearable albeit unpleasant jab to the abdomen or thigh. But drug ...

New data on GLP-1 injectable weight loss drugs has found that while they have several health benefits, the list of potentially dangerous side effects remains. Doctors say that for many patients, these ...

People experiencing "ghost fat" may instinctively continue behaviors they developed when they were larger.

Editor's Note: The following is part of a class project originally initiated in the classroom of Ball State University professor Adam Kuban in fall 2021. Kuban continued the project this spring ...

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

Since they debuted, injectable GLP-1 drugs like Ozempic have been in high demand. In addition to treating diabetes and obesity, these medications have cardiovascular benefits, and there’s evidence ...